Content Block Tag: NRG-LU003

‘Text/HTML’ of page ‘NRG-LU003’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-LU003’

                        Frequently Asked Questions   Below, you can find FAQs about clinical research and this particular clinical trial.  

‘Text/HTML’ of page ‘NRG-LU003’

          Where can I get more information?   Additional information for the NRG Oncology GI004 trial can be found in the Patient Study Brochure      

‘Text/HTML’ of page ‘NRG-LU003’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-LU003’

‘Text/HTML’ of page ‘NRG-LU003’

Am I eligible for this study? Your healthcare team is the best source for information about your treatment options, including the ability to help you make decision to participate in cancer clinical trials. Be sure to take the information you find to your doctor for discussion about possible studies and for questions and concerns. Are […]

‘Text/HTML’ of page ‘NRG-LU003’

‘Text/HTML’ of page ‘NRG-LU003’

Am I eligible for this study? Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take the information you find to your doctor for discussion about possible studies and for questions and concerns.  Are there other studies I might be eligible for? Please talk to your healthcare team […]

‘Text/HTML’ of page ‘NRG-LU003’

    About This Study NRG-GI004 is a clinical trial that will study three treatment options for patients with colorectal cancer that has spread to other parts of their body (metastatic). This study is specifically for patients who have a particular type of colorectal cancer called “MSI-high” or “DNA mismatch repair deficient”. This can usually be known by […]

‘Text/HTML’ of page ‘NRG-LU003’

Clinical Studies FAQ